ON THE SAFETY OF CONTRAST MEDIA USAGE DURING CORONARY ANGIOPLASTY IN KIDNEY TRANSPLANT RECIPIENTS
https://doi.org/10.15825/1995-1191-2010-2-43-47
Abstract
In the present study influence of contrast media on renal transplant function in patients with ischemic heart disease treated by coronary angioplasty and stenting waz estimated. Results are based on clinical and angiographic data, the analysis of amount of contrast media, average speed of it introduction, level of creatinine before and at the first 48 hours after coronary angioplasty in 42 patients with renal transplant.
About the Authors
I. G. RyadovoyRussian Federation
N. A. Tomilina
Russian Federation
V. V. Chestuhin
Russian Federation
I. G. Kim
Russian Federation
A. B. Mironkov
Russian Federation
References
1. Томилина Н.А., Столяревич Е.С., Ким И.Г. Клиничес- кая трансплантология почки: нефрологические ас- пекты, роль заместительной терапии терминальной хронической почечной недостаточности // Очерки клинической трансплантологии. М., 2009. С. 107– 174.
2. Шумаков В.И., Томилина Н.А, Ким И.Г. и др. Ише- мическая болезнь сердца после трансплантации поч- ки: эпидемиология, факторы риска и хирургические подходы к лечению // Вестник Российской академии медицинских наук. 2006. No 11.
3. Ким И.Г., Честухин В.В., Казаков Э.И. и др. Эф- фективность хирургического лечения ишемической болезни сердца у реципиентов почечного аллотранс- плантата // Вестник трансплантол. и искусств. орга- нов. 2007. No 6.
4. Aakhus S., Wideroe T.E. Cardiovascular morbidity and risk factors in renal transplant recipients // Nephrol. Dial. Transplant. 1999. Vol. 14. Р. 648–654.
5. Kahan B., Ponticelli C. Cardiovascular disease and its causes // Principls and practice of renal transplantation. London. 2000. P. 589–614.
6. Kasiske B., Guijarro C., Massy Z. et al. Cardiovascular disease after renal transplantation // J. Am. Soc. Nephrol. 1996. Vol. 7. P. 158–165.
7. Hemmelgarn B.R., Ghali W.A., Quan H. et al. Poor long- term survival after coronary angiography in patients with renal insufficiency //Am. J. Kidney Dis. 2000. Vol. 37. P. 64–72.
8. Jo S.H., Youn T.J., Koo B.K. et al. Renal toxity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography. The RECOVER study: a randomized control trial // J. Am. Coll. Cardiol. 2006. Vol. 48. P. 924–930.
9. Weisberg L.S., Kurnik P.B., Kurnic B.R. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus //Kidney hit. 1994. Vol. 45. P. 259–265.
10. Barett B.J., Parfrey P.S. Preventing nephropathy induced by contrast medium // N. Eng. J. Med. 2006. Vol. 354. P. 379–386.
11. Parfrey P.S., Griffits S.M., Barrett B.J. et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective con- trolled study // N. Engl. J. Med. 1989. Vol. 320. 143 p.
12. Rudnick M.R., Goldfarb S., Wexter L. et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. Kidney int. 1995. Vol. 45. 254 p.
13. Schwab S.J., Hlatky M.A., Pieper K.S. et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent // N. Engl. J. Med. 1989. Vol. 320. 149 p.
Review
For citations:
Ryadovoy I.G., Tomilina N.A., Chestuhin V.V., Kim I.G., Mironkov A.B. ON THE SAFETY OF CONTRAST MEDIA USAGE DURING CORONARY ANGIOPLASTY IN KIDNEY TRANSPLANT RECIPIENTS. Russian Journal of Transplantology and Artificial Organs. 2010;12(2):43-47. (In Russ.) https://doi.org/10.15825/1995-1191-2010-2-43-47